Empozin M (12.5/500mg) 14 Tablets
Empagliflozin 12.5mg and metformin 500mg for type 2 diabetes.
Empozin M (12.5/500mg) 14 Tablets combines empagliflozin (SGLT2) 12.5mg and metformin 500mg for type 2 diabetes when dual therapy is needed. Take once or twice daily with meals as directed; swallow whole.
Purpose
Treatment of type 2 diabetes mellitus as adjunct to diet and exercise when combination therapy is appropriate.
Ingredients
Empagliflozin 12.5mg and metformin hydrochloride 500mg per tablet.
Warnings
Contraindicated in severe renal impairment and diabetic ketoacidosis. Not for type 1 diabetes. Risk of genital and urinary infections. Avoid excessive alcohol.
Side Effects
Nausea, diarrhoea, urinary tract infections, genital mycotic infections. Rare: ketoacidosis. Report unusual tiredness or abdominal pain.
Storage Instructions
Store below 30°C in a dry place. Keep in original pack; protect from moisture.
| Brand | Macter |
| Status | Active |
Related Products
